THE Therapeutic Goods
Administration (TGA) has issued a
new set of cost recovery statements
relating to their activities, including
that the estimated revenue from
complementary medicines was
$11.9m in 2013-14, while expenses
were $16m, leaving a deficit of
$4.1m.
The forecast for 2014-15 was
expenses of $15.6m and revenue of
$11.6m.
Estimated application fees
amounted to $2.4m in 2013-14
and were forecast to be $1.8m in
2014-15.
For details go to www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 21 Jul 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Jul 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.